Previous 10 | Next 10 |
Wilmington, DE, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its third quarter 2022 financial results on Wednesday...
Summary Jeff Smith’s 13F portfolio value decreased from $7.54B to $5.50B this quarter. Starboard Value increased NortonLifeLock and Mercury Systems while decreasing ON Semiconductor, Huntsman Corp, Corteva, Enovis, and Kohl’s. The largest three individual stock p...
Wilmington, DE, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Today, Enovis Corporation (NYSE: ENOV), an innovation-driven, medical technology company, announced it will showcase its foot & ankle continuum of care portfolio at the American Orthopaedic Foot & Ankle Society® (AOFAS) annual ...
Summary Financial markets, over the past several years, is beginning a long overdue and, in our view, long duration reversion. It is our view that this “change” has just started, it is not remotely over and it is just starting to reveal its scope. We cannot prete...
Enovis Corporation (ENOV) Q2 2022 Results Conference Call August 04, 2022 08:00 AM ET Company Participants Derek Leckow - Vice President, Investor Relations Matt Trerotola - Chief Executive Officer Chris Hix - Executive Vice President & Chief Financial Office...
Enovis Corporation press release ( NYSE: ENOV ): Q2 Non-GAAP EPS of $0.59 beats by $0.09 . Revenue of $395M (+10.9% Y/Y) misses by $5.23M . For further details see: Enovis Corporation Non-GAAP EPS of $0.59 beats by $0.09, revenue of $395M misses by $5.23M...
Sales of $395 million include 11 % reported growth, 3% organic growth and 5 % sales-per-day growth Reported o perating income of $ 6 million, while a djusted EBITDA increased 11 % to $ 56 million R...
ABMD , ABUS , ACIW , ADAP , OTCQX:ADDYY , ADT , AG , AGIO , AHH , APD , APO , APTV , ARW , ATI , AUPH , AUTL , AZEK , BABA , BALL , BALY , OTCPK:BAYZF , BCE , BCRX , BDX , BKI , CBRE , ...
Alphyn Capital Management LLC (“ACML”) is a registered investment advisor in New York. We help clients invest in high quality public companies to both preserve and grow their wealth over the long-term. The Master Account, in which I am personally invested alongside SMA c...
Enovis ( NYSE: ENOV ) said it launched its FDA-cleared augmented reality (AR) surgical guidance system ARVIS. The company added that ARVIS (Augmented Reality Visualization and Information System) was engineered for orthopedic surgeons so they can visualize precisi...
News, Short Squeeze, Breakout and More Instantly...
2024-07-02 15:15:06 ET Needham analyst issues BUY recommendation for ENOV on July 2, 2024 01:01PM ET. The previous analyst recommendation was Buy. ENOV was trading at $44.37 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst ...
2024-07-02 09:00:08 ET Vijay Kumar from Evercore ISI issued a price target of $62.00 for ENOV on 2024-07-02 08:02:00. The adjusted price target was set to $62.00. At the time of the announcement, ENOV was trading at $44.35. The overall price target consensus is at $67.00...
Wilmington, DE, May 10, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences: Bank of America Healthcare Conference: Ben ...